Biomea Fusion Company Insiders

BMEA Stock  USD 7.24  0.22  3.13%   
Biomea Fusion employs about 107 people. The company is managed by 11 executives with a total tenure of roughly 250 years, averaging almost 22.0 years of service per executive, having 9.73 employees per reported executive. Analysis of Biomea Fusion's management performance can provide insight into the company performance.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomea Fusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.

Biomea Fusion Management Team Effectiveness

The company has return on total asset (ROA) of (0.5638) % which means that it has lost $0.5638 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0451) %, meaning that it created substantial loss on money invested by shareholders. Biomea Fusion's management efficiency ratios could be used to measure how well Biomea Fusion manages its routine affairs as well as how well it operates its assets and liabilities. As of December 1, 2024, Return On Tangible Assets is expected to decline to -0.62. The current year's Return On Capital Employed is expected to grow to -0.68. At present, Biomea Fusion's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 3 M, whereas Total Assets are forecasted to decline to about 127.1 M.
As of December 1, 2024, Common Stock Shares Outstanding is expected to decline to about 23.9 M. The current year's Net Loss is expected to grow to about (70 M)

Biomea Fusion Workforce Comparison

Biomea Fusion is rated second in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 413. Biomea Fusion totals roughly 107 in number of employees claiming about 26% of equities under Health Care industry.

Biomea Fusion Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biomea Fusion insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biomea Fusion's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Biomea Fusion insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2023-12-01
0.75
3
4
 7,345 
 21,000 
2023-06-01
1.0
6
6
 39,218 
 600,000 
2023-03-01
5.0
5
1
 1,198,650 
 200,000 
2022-06-01
4.5
9
2
 216,131 
 4,400,000 
2021-06-01
1.0909
12
11
 6,081,011 
 1,087,351 

Biomea Fusion Notable Stakeholders

A Biomea Fusion stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biomea Fusion often face trade-offs trying to please all of them. Biomea Fusion's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biomea Fusion's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Franco CPACFO OfficerProfile
Juan MDChief OfficerProfile
Caroline DupontSenior ContractsProfile
Naomi CretcherChief OfficerProfile
Heow TanChief OfficerProfile
Stephan MDChief OfficerProfile
Franco ValleCFO OfficerProfile
Ravi UpasaniExecutive PropertyProfile
Ramses ErdtmannPresident, CoFounderProfile
Thomas ButlerChairman CoFounderProfile
Thorsten KirschbergExecutive ChemistryProfile

About Biomea Fusion Management Performance

The success or failure of an entity such as Biomea Fusion often depends on how effective the management is. Biomea Fusion management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biomea management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biomea management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.59)(0.62)
Return On Capital Employed(0.71)(0.68)
Return On Assets(0.59)(0.62)
Return On Equity(0.69)(0.66)
Please note, the presentation of Biomea Fusion's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biomea Fusion's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Biomea Fusion's management manipulating its earnings.

Biomea Fusion Workforce Analysis

Traditionally, organizations such as Biomea Fusion use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biomea Fusion within its industry.

Biomea Fusion Manpower Efficiency

Return on Biomea Fusion Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.1M
Net Loss Per Executive10.7M
Working Capital Per Employee1.5M
Working Capital Per Executive14.2M

Complementary Tools for Biomea Stock analysis

When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Valuation
Check real value of public entities based on technical and fundamental data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings